Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;30(1):125-42.
doi: 10.1016/j.iac.2009.10.004.

Radiosensitive severe combined immunodeficiency disease

Affiliations

Radiosensitive severe combined immunodeficiency disease

Christopher C Dvorak et al. Immunol Allergy Clin North Am. 2010 Feb.

Abstract

Inherited defects in components of the nonhomologous end-joining DNA repair mechanism produce a T-B-NK+ severe combined immunodeficiency disease (SCID) characterized by heightened sensitivity to ionizing radiation. Patients with the radiosensitive form of SCID may also have increased short- and long-term sensitivity to the alkylator-based chemotherapy regimens that are traditionally used for conditioning before allogeneic hematopoietic cell transplantation (HCT). Known causes of radiosensitive SCID include deficiencies of Artemis, DNA ligase IV, DNA-dependent protein kinase catalytic subunit, and Cernunnos-XLF, all of which have been treated with HCT. Because of these patients' sensitivity to certain forms of chemotherapy, the approach to donor selection and the type of conditioning regimen used for a patient with radiosensitive SCID requires careful consideration. Significantly more research needs to be done to determine the long-term outcomes of patients with radiosensitive SCID after HCT and to discover novel nontoxic approaches to HCT that might benefit those patients with intrinsic radiosensitivity and chemosensitivity as well as potentially all patients undergoing an HCT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
V(D)J Recombination: Initial process and hairpin formation. RSS = Recombination Signal Sequences; RAG = Recombinase Activating Gene Protein (Adapted with permission from: Cowan, MJ. T cell negative, B cell negative, NK cell positive severe combined immunodeficiency disease. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA 2009. Copyright © 2009 UpToDate, Inc. For more information visit www.uptodate.com.)
Figure 2
Figure 2
The Non-Homologous End Joining Pathway DNA PKcs = DNA-dependent protein kinase catalytic subunit; XRCC4 = X-ray cross-complementation group 4 protein (Adapted with permission from: Cowan, MJ. T cell negative, B cell negative, NK cell positive severe combined immunodeficiency disease. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA 2009. Copyright © 2009 UpToDate, Inc. For more information visit www.uptodate.com.)

References

    1. Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood. 1998;91(10):3646–3653. - PubMed
    1. Bertrand Y, Landais P, Friedrich W, et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. J Pediatr. 1999;134(6):740–748. - PubMed
    1. Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361(9357):553–560. - PubMed
    1. Mazzolari E, Forino C, Guerci S, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120(4):892–899. - PubMed
    1. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508–518. - PubMed

Publication types

MeSH terms